Carr F, Géranton S, Hunt S (2014) Descending controls modulate inflammatory joint pain and regulate CXC chemokine and iNOS expression in the dorsal horn. Mol Pain 10:39. doi: 10.1186/1744-8069-10-39

Summary: Peripheral joint pathology in conditions such as osteoarthritis does not always correlate to the amount of pain experienced, indicating that chronic pain is present. The role of descending facilitation in this form of chronic pain has not been investigated. The authors examined the role of mu opioid receptor-expressing cells in the rostral vental medulla (RVM) in behavioral hypersensitivity seen in joint pain models. Rats received 1.5 pmol of Dermorphin-SAP (Cat. #IT-12) into the RVM. Lesioned animals displayed prolonged attenuation of hypersensitivity, and altered expression of several genes was detected by qPCR, indicating that descending facilitation in the RVM is involved in joint pain behavior.

Related Products: Dermorphin-SAP / MOR-SAP (Cat. #IT-12)

Murray RC, Gilbert YE, Logan AS, Hebbard JC, Horner KA (2014) Striatal patch compartment lesions alter methamphetamine-induced behavior and immediate early gene expression in the striatum, substantia nigra and frontal cortex. Brain Struct Funct 219:1213-1229. doi: 10.1007/s00429-013-0559-x

Summary: In this work, the authors investigated the function of the patch compartment in abnormally repetitive motor actions (stereotypy) in response to a psychostimulant such as methampheta-mine (meth). Rats received bilateral injections of Dermorphin-SAP (Cat. #IT-12; 17 ng) into the rostral striatum. When treated with meth, lesioned animals displayed reduced stereotypy, increased motor activity, and enhanced c-Fos expression.

Related Products: Dermorphin-SAP / MOR-SAP (Cat. #IT-12)

Biggs LM, Simonton AR, Meredith M (2012) Intercalated nucleus modulates chemosensory processing in medial amygdala. Neuroscience 2012 Abstracts 781.07. Society for Neuroscience, New Orleans, LA.

Summary: The vomeronasal organ is necessary for interpretation by naive rodents (hamsters, mice) of many chemosensory signals. Information is relayed to medial amygdala (Me) via the accessory olfactory bulbs. FRA (Fos related antigen) responses in Me to chemosensory cues suggest this area is important for categorization of cues based on biological relevance to the animal. Anterior Me (MeA) is activated by all chemosensory cues (conspecific and heterospecific). Posterior Me (MeP) activates for conspecific and biologically relevant heterospecific stimuli only. Other heterospecific stimuli suppress MeP, apparently via GABA inhibition, while the adjacent medial-caudal intercalated nucleus (m-ICNc) is activated. Intercalated nuclei (ICNs) are groups of GABAergic cells between amygdala main-divisions. Those adjacent to basolateral and central amygdala (BLA, CeA) are known to mediate BLA, CeA responses via GABA inhibition, modulated by inhibitory DA-D1 receptors on ICN cells. We hypothesize that m-ICNc modulates MeP in a similar manner, as suggested by FRAs data, but this has not yet been tested directly. In hamsters, we show a hyperpolarization of MeP cells and suppression of ongoing spiking in whole-cell slice electrophysiology using in-slice stimulation of m-ICNc. The effect of dopamine and other modulators on this functional relationship is under study with agonists and antagonists. ICN, but not Me, cells carry mu-opioid receptors (MORs). In mice, we use Dermorphin-Saporin, a toxin that selectively destroys MOR+ neurons, to lesion m-ICNc to assess its role in chemosensory responses in MeP. Also in mice, a specific MUP protein in male urine (mMU) facilitates learning of a male’s chemosensory signature by females. We have quantified Me response to high and low molecular weight (HMW, LMW) fractions (LMW lacks protein) and whole mMU using FRAs immediate early gene expression. Preliminary results show no significant difference between HMW, LMW, or whole mMU in Me, however within the BLA (involved in volatile odor learning), there are significant differences in activity between stimuli in females without post-weaning exposure to male urine and no prior exposure to adult male urine.

Related Products: Dermorphin-SAP / MOR-SAP (Cat. #IT-12)

Carr F, Géranton SM, Hunt SP (2012) Descending facilitation contributes to changes in dorsal horn gene expression in a rat model of inflammatory joint pain. Neuroscience 2012 Abstracts 785.07. Society for Neuroscience, New Orleans, LA.

Summary: Chronic pain is associated with increased excitability and changes in gene expression within the dorsal horn. Descending facilitation from the rostral ventromedial medulla (RVM) is known to contribute to this excitability and behavioural hypersensitivity in a number of pain states. This would suggest that some of the gene changes associated with chronic pain could be driven by descending pathways terminating in the dorsal horn. We have previously demonstrated that ablation of a subset of RVM neurons expressing the mu opioid receptor (MOR) attenuates behavioural hypersensitivity following joint inflammation. The aim of the present study was to combine lesion of the RVM with microarray analysis of the dorsal horn to identify genes regulated by descending facilitation in this pain model. Selective lesion of MOR expressing cells of the RVM was carried out in rats by microinjection of the selective toxin dermorphin-saporin. Non-lesioned controls received vehicle microinjection. 4 weeks after the lesion procedure when depletion of the MOR+ cells was complete, both groups received an injection of 10μl Complete Freund’s Adjuvant to the left ankle joint. 7 days later the animals were sacrificed and the ipsilateral quadrant of the dorsal horn of the spinal cord lumbar region (L4-L6) removed. RNA was extracted and microarray analysis carried out using Affymetrix GeneChip Rat Gene 1.0 ST Arrays. Raw data was analysed in R using Bioconductor open source software. Limma testing was applied and a list of genes differentially regulated in animals with prior RVM lesion compared to non-lesioned controls was generated. The majority of differentially regulated genes (73%) were downregulated in the lesioned group. We used the DAVID bioinformatics resource to cluster the genes into groups with similar functional annotations (Huang et al., 2009). This analysis identified 16 gene clusters with significantly enriched functional annotations. Among these enriched functions were ribosomal function and biogenesis, inflammatory response (including the chemokine CXCL10), GPCR signalling (including the serotonin receptor 5HTR1D) and transcriptional regulation (including the transcriptional repressor RCOR2). Following on from identification of functional categories, validation of genes of interest was carried out using RT-qPCR. Our findings suggest that descending facilitation contributes to gene expression changes within the dorsal horn and that this may correlate with behavioural hypersensitivity observed in chronic pain.

Related Products: Dermorphin-SAP / MOR-SAP (Cat. #IT-12)

Sikandar S, Bannister K, Dickenson AH (2012) Brainstem facilitations and descending serotonergic controls contribute to visceral nociception but not pregabalin analgesia in rats. Neurosci Lett 519(1):31-36. doi: 10.1016/j.neulet.2012.05.009

Summary: Neurons in the rostral ventromedial medulla (RVM) are classified as ON, OFF, or NEUTRAL based on firing patterns in response to noxious somatic stimulation. ON cells express μ-opioid receptors, and are therefore a target for dermorphin-SAP (Cat. #IT-12). The authors injected the RVM of rats with 3 pmol of dermorphin-SAP; Saporin (Cat. #PR-01) was used as a control. Results show the μ-opioid receptor population is not needed for the function of analgesics through the serotonergic system.

Related Products: Dermorphin-SAP / MOR-SAP (Cat. #IT-12), Saporin (Cat. #PR-01)

Carr F, Géranton SM, Hunt SP (2011) The role of descending facilitation in the initiation and maintenance of mechanical hypersensitivity following inflammation. Neuroscience 2011 Abstracts 702.10. Society for Neuroscience, Washington, DC.

Summary: Central sensitisation is the key mechanism involved in the generation of mechanical hypersensitivity associated with tissue injury. Dorsal horn excitability is subject to regulation by descending modulation via the rostral ventromedial medulla (RVM) and enhanced descending facilitation under conditions of persistent nociceptive input contributes to the maintenance of mechanical hypersensitivity in chronic pain states. Depletion of mu-opioid receptor expressing (MOR+) cells of the RVM and depletion of spinal serotonin have been used previously to demonstrate the contribution of descending facilitation to the maintenance of neuropathic pain. Here we have used the same ablation techniques to investigate the contribution of descending pathways to the initiation and maintenance of mechanical hypersensitivity associated with ankle joint inflammation. Male Sprague-Dawley rats (215-220g at the time of injection) received bilateral microinjections of the selective cytotoxin dermorphin-saporin (1.5pM each side). 28 days later the animals received either an injection of 10μl Complete Freund’s Adjuvant (CFA) to the left ankle joint or underwent a sham procedure. Mechanical hypersensitivity of the hindpaw plantar surface was assessed using von Frey hairs from 2 hours up to 8 days post CFA injection. In a separate group of rats (160-180g at the time of injection) depletion of spinal serotonin was out carried out by intrathecal administration of 5,7-dihydroxytrptamine (5,7-DHT). Animals received either 10 μl of 5,7-DHT in saline (6μg/μl) or vehicle control. 6 days later animals received either CFA injection or underwent a sham procedure and mechanical hypersensitivity was assessed as in the dermorphin-saporin experiment. Depletion of the MOR+ cells of the RVM and of spinal serotonin was confirmed using immunohistochemistry. Dermoprhin-saporin pre-treatment resulted in significantly increased paw withdrawal thresholds from 6 hours up to 8 days following CFA injection (p < 0.01, ANOVA with repeated measures). In contrast depletion of spinal serotonin by 5,7-DHT led to a smaller attenuation of mechanical hypersensitivity at 24 hours and 48 hours following inflammation (LSD post hoc test, p < 0.01) but did not result in significantly increased paw withdrawal thresholds at the earlier time points.

Related Products: Dermorphin-SAP / MOR-SAP (Cat. #IT-12)

Reynolds J, Bilsky EJ, Meng ID (2011) Selective ablation of mu-opioid receptor expressing neurons in the rostral ventromedial medulla attenuates stress-induced mechanical hypersensitivity. Life Sci 89(9-10):313-9. doi: 10.1016/j.lfs.2011.06.024

Summary: Animals have been shown to develop hyperalgesia in response to chronic stress. Recent data has implicated the rostroventromedial medulla (RVM) in this process. In order to clarify what role mu-opioid receptor expressing neurons in the RVM play in rat, the authors injected 1.8 pmol of dermorphin-SAP (Cat. #IT-12) into the RVM. The rats were then subjected to a model designed to produce hypersensitivity in the hind paw. Stress-induced behavior did not change in the lesioned animals, but mechanical hypersensitivity was reduced.

Related Products: Dermorphin-SAP / MOR-SAP (Cat. #IT-12)

Lemons LL, Chatterjee K, Wiley RG (2010) Neuropeptide receptor co-expression in superficial dorsal horn: Effects of galanin-saporin, neuropeptide y-saporin and dermorphin-saporin. Neuroscience 2010 Abstracts 585.5/XX19. Society for Neuroscience, San Diego, CA.

Summary: We have previously shown that the role of specific neurons in behavioral processes can be fruitfully studied using targeted toxins. Toxins composed of a targeting neuropeptide coupled to the ribosomal-inactivating toxin, saporin, are used to selectively destroy superficial dorsal horn neurons expressing the cognate peptide receptors followed by assessment of changes in pain behavior. In the present study, we sought to compare the anatomic effects of three closely related targeted toxins, each with different nocifensive behavioral effects. Rats were given single lumbar intrathecal injections of either galanin-saporin (Gal-SAP), neuropeptide Y-saporin (NPY-SAP), or dermorphin-saporin (Derm-SAP). Lumbar spinal cord sections from each rat were stained for each of the three receptors, GalR-1, Y1R and MOR (mu opiate) using standard immunoperoxidase technique. Each toxin produced a significant decrease in staining for its cognate receptor. Gal-SAP animals showed no change in either MOR or Y1R staining. NPY-SAP rats showed decreased staining for both GalR1 and MOR, and Derm-SAP rats were assessed for changes in expression of GalR1 and Y1R. These findings suggest overlaps between the populations of neurons that express the GalR1, Y1R, and MOR. Specifically, Y1R-expressing neurons also express GalR1 and MOR, probably by separate subpopulations of Y1R neurons. The results also suggest either that Gal-SAP only kills neurons that do not express either of the other two receptors, or some of the observed loss of receptors after NPY-SAP is due to secondary (transsynaptic) effects. Double- and triple-label fluorescent immunohistochemistry will be used to directly visualize receptor co-expression patterns and targeted toxin effects. These results will be valuable in interpreting the unique nocifensive behavioral effects of each of these targeted toxins.

Related Products: Dermorphin-SAP / MOR-SAP (Cat. #IT-12), Galanin-SAP (Cat. #IT-34), NPY-SAP (Cat. #IT-28)

Ng TB, Wong JH, Wang H (2010) Recent progress in research on ribosome inactivating proteins. Curr Protein Pept Sci 11(1):37-53. doi: 10.2174/138920310790274662

Summary: This review discusses recent literature on ribosome inactivating proteins including the use of saporin-based conjugates in neuroscience and cancer research. Brief descriptions of research done using 192-IgG-SAP (Cat. #IT-01), OX7-SAP (Cat. #IT-02), dermorphin-SAP (Cat. #IT-12), anti-SERT-SAP (Cat. #IT-23), SSP-SAP (Cat. #IT-11), anti-DBH-SAP (Cat. #IT-03), CTB-SAP (Cat. #IT-14), and other conjugates are provided along with basic information about ribosome inactivating proteins.

Related Products: 192-IgG-SAP (Cat. #IT-01), OX7-SAP (Cat. #IT-02), Dermorphin-SAP / MOR-SAP (Cat. #IT-12), Anti-SERT-SAP (Cat. #IT-23), SSP-SAP (Cat. #IT-11), Anti-DBH-SAP (Cat. #IT-03), CTB-SAP (Cat. #IT-14)

Kline IV RH, Wiley RG (2009) Spinal µ-opiate receptor (MOR)-expressing dorsal horn neurons: Role in modulating pain and opiate analgesia. Neuroscience 2009 Abstracts 560.13/CC72. Society for Neuroscience, Chicago, IL.

Summary: Selective destruction of MOR-expressing interneurons in lamina II of the dorsal horn of the spinal cord increases reflex nocifensive responses to formalin and decreases the anti-nociceptive effects of morphine on the hotplate and in the formalin test. The interpretation of these studies is limited because reflex-based assays may not accurately reflect the cerebral component of nociception. Therefore, we sought to determine the effects of selectively destroying MOR-expressing dorsal horn neurons on baseline operant responses to aversive thermal and mechanical stimuli in a shuttle box task and effects of systemic morphine and naloxone in the same task. The preference apparatus consisted of a 15 X 15 X 30 cm smoked Plexiglas vented chamber placed upon two adjoining temperature-controlled smooth aluminum floor plates (thermal preference task) or one smooth temperature-controlled floor plate adjoined to a room temperature surface covered with 40 grit sandpaper (mechanical preference task). For both preference tasks, response functions were obtained by pairing a 44°C plate or the sandpaper surface with either 11°, 16°, 25°, 38° or 46°C. Rats were intrathecally injected over the lumbar cord with either 625ng of derm-sap (n=7) or blank-sap (n=6) followed by daily thermal or mechanical preference testing on a randomized schedule. Derm-sap treated rats showed enhanced avoidance of aversive thermal stimuli and the aversive mechanical stimulus. Morphine and naloxone significantly altered responses of control rats (blank-sap), but not derm-sap rats, in both thermal and mechanical preference tasks. We interpret these results as showing that the derm-sap lesion produces hyperalgesia/allodynia, impairs the anti-nociceptive and analgesic effects of morphine and therefore indicating that postsynaptic dorsal horn MOR-expressing neurons play a key role in modulating nociception, pain and opiate analgesia. Dysfunction of these neurons may also play a role in pathological pain states.

Related Products: Dermorphin-SAP / MOR-SAP (Cat. #IT-12)